Advertisement
Home Tags Eye / Vision Problems: Misc.

Tag: Eye / Vision Problems: Misc.

March 2018 Briefing – Ophthalmology

0
Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for March 2018. This roundup includes the latest...
For children with retinitis pigmentosa

Vitamin A Appears Helpful in Pediatric Retinitis Pigmentosa

0
Supplementation associated with slower loss of cone electroretinogram amplitude
Intravitreal anti-vascular endothelial growth factor treatment is not associated with increased risk of systemic adverse events for patients with neovascular age-related macular degeneration

Intravitreal Anti-VEGF Use Not Tied to Systemic Adverse Events

0
Risk not up in neovascular age-related macular degeneration, diabetic macular edema
Few patients with irreversible vision impairment are referred for vision rehabilitation

Low Rate of Referral for Low-Vision Rehabilitation

0
Few patients with irreversible vision impairment are referred for rehabilitation services
For patients with diabetic macular edema

Repeated Ranibizumab Doesn’t Impair Macular Perfusion

0
Findings in patients with diabetic macular edema who completed 36 months of RESTORE study
Most patients with uveal melanoma have unmet health information and psychological needs

Unmet Health Needs for Patients With Uveal Melanoma

0
Most express unmet needs at 1 week, 3 months after diagnosis; drop in unmet needs over time

February 2018 Briefing – Ophthalmology

0
Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for February 2018. This roundup includes the latest...
Retinopathy is associated with accelerated rates of 20-year cognitive decline

Retinopathy Associated With Accelerated Cognitive Decline

0
20-year cognitive change is greater with moderate-to-severe retinopathy than no retinopathy
For infants born at a gestational age of less than 28 weeks

Low Postnatal Levels of Arachidonic Acid Linked to ROP

0
Evaluating arachidonic acid and gestational age identifies ROP with a sensitivity >90 percent
For patients with diabetic macular edema

Persistent DME More Likely With Bevacizumab Treatment

0
Persistent diabetic macular edema more likely with bevacizumab than aflibercept or ranibizumab